First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting
-
* Corresponding author: Lillian L Siu Lillian.Siu@uhn.on.ca
Journal of Hematology & Oncology 2008, 1:20 doi:10.1186/1756-8722-1-20
Accesses
- Last 30 days: 139 accesses
- Last 365 days: 1134 accesses
- All time: 4756 accesses